HALDOL Side Effects

6783186-3 | Thrombosis
on Jun 14, 2010 Female patient from GERMANY , 64 years of age, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: thrombosis. Haldol dosage: . During the same period patient was treated with DIPIPERON (View Dipiperon Review and Dipiperon Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

6780786-1 | Agitation, Intentional Overdose, Self Injurious Behaviour, Sopor
Patient was taking Haldol (View Usage). Patient had the following side effects: agitation, intentional overdose, self injurious behaviour, sopor on Jun 14, 2010 from ITALY Additional patient health information: Female patient , 43 years of age, weighting 110.2 lb, . Haldol dosage: . During the same period patient was treated with VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ).

6780785-X | Self Injurious Behaviour, Sluggishness
Adverse event was reported on Jun 13, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) . Location: ITALY , 73 years of age, After Haldol was administered, patient had the following side effects: self injurious behaviour, sluggishness. During the same period patient was treated with TALOFEN (View Talofen Review and Talofen Label ).

6779040-3 | Coma, Self Injurious Behaviour
on Jun 12, 2010 Male patient from ITALY , 64 years of age, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: coma, self injurious behaviour. Haldol dosage: . During the same period patient was treated with ELOPRAM (View Elopram Review and Elopram Label ), DELORAZEPAM (View Delorazepam Review and Delorazepam Label ), FLUVOXAMIN (View Fluvoxamin Review and Fluvoxamin Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), TALOFEN (View Talofen Review and Talofen Label ).


6775258-4 | Confusional State, Self Injurious Behaviour, Sluggishness
on Jun 11, 2010 Female patient from ITALY , 36 years of age, was treated with Haldol (View Usage). Patient had the following side effects: confusional state, self injurious behaviour, sluggishness. Haldol dosage: . During the same period patient was treated with EN (View En Review and En Label ), AKINETON (View Akineton Review and Akineton Label ).

6774916-5 | Aspiration, Heart Rate Increased, Tremor
Patient was taking Haldol (View Usage). After Haldol was administered, patient had the following side effects: aspiration, heart rate increased, tremor on Jun 16, 2010 from UNITED STATES Additional patient health information: Female patient , 96 years of age, weighting 110.0 lb, . Haldol dosage: .

6774165-0 | Miosis, Self Injurious Behaviour, Sopor
Adverse event was reported on Jun 09, 2010 by a Female patient taking Haldol (View Usage) (Dosage: ) was diagnosed with self injurious behaviour and. Location: ITALY , 32 years of age, Patient experienced the following unwanted or unexpected effects: miosis, self injurious behaviour, sopor. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), CIPRALEX (View Cipralex Review and Cipralex Label ), SEROQUEL (View Seroquel Review and Seroquel Label ).

6771082-7 | Intentional Overdose, Self Injurious Behaviour
on Jun 08, 2010 Female patient from ITALY , 54 years of age, was treated with Haldol (View Usage). Patient had the following side effects: intentional overdose, self injurious behaviour. Haldol dosage: .

6771081-5 | Agranulocytosis, Dyspnoea, Psychomotor Skills Impaired, Sluggishness, Stress, Weight Increased
on Jun 07, 2010 Male patient from GERMANY , 54 years of age, weighting 194.0 lb, was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: agranulocytosis, dyspnoea, psychomotor skills impaired, sluggishness, stress (What is stress?), weight increased. Haldol dosage: . During the same period patient was treated with LEPONEX (View Leponex Review and Leponex Label ). Patient was hospitalized.

6763968-4 | Mydriasis, Self Injurious Behaviour, Sluggishness, Sopor, Tachycardia
Patient was taking Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: mydriasis, self injurious behaviour, sluggishness, sopor, tachycardia on Jun 04, 2010 from ITALY Additional patient health information: Female patient , 73 years of age, . Haldol dosage: . During the same period patient was treated with AKINETON (View Akineton Review and Akineton Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), SAMYR (View Samyr Review and Samyr Label ).

6762296-0 | Self Injurious Behaviour, Sopor
Adverse event was reported on Jun 03, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) . Location: ITALY , 54 years of age, Patient had the following side effects: self injurious behaviour, sopor. During the same period patient was treated with GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6760662-0 | Intentional Overdose, Self Injurious Behaviour
on Jun 02, 2010 Female patient from ITALY , 16 years of age, weighting 143.3 lb, was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: intentional overdose, self injurious behaviour. Haldol dosage: 20ml.

6752457-9 | Erythema, Fluid Retention, Musculoskeletal Stiffness, Nasal Congestion, Oedema, Photosensitivity Reaction, Poor Peripheral Circulation, Skin Irritation, Weight Increased
on May 28, 2010 Female patient from SWEDEN , 62 years of age, weighting 240.3 lb, was diagnosed with hallucination and was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, fluid retention, musculoskeletal stiffness, nasal congestion, oedema, photosensitivity reaction, poor peripheral circulation, skin irritation, weight increased. Haldol dosage: .

6752247-7 | Myoclonus, Self Injurious Behaviour
Patient was taking Haldol (View Usage). Patient had the following side effects: myoclonus, self injurious behaviour on May 26, 2010 from ITALY Additional patient health information: Male patient , 21 years of age, . Haldol dosage: .

6748654-9 | Antiphospholipid Syndrome, Pneumonia, Pulmonary Embolism, Thrombophlebitis Superficial
Adverse event was reported on May 27, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) was diagnosed with acute psychosis and. Location: AUSTRIA , 23 years of age, After Haldol was administered, patient had the following side effects: antiphospholipid syndrome, pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?), thrombophlebitis superficial. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), GEWACALM (View Gewacalm Review and Gewacalm Label ), LOVENOX (View Lovenox Review and Lovenox Label ), MARCUMAR (View Marcumar Review and Marcumar Label ). Patient was hospitalized.

6748436-8 | Dyspnoea, Dystonia, Muscle Spasms, Nervous System Disorder, Thinking Abnormal
on May 27, 2010 Male patient from UNITED STATES , weighting 185.0 lb, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, dystonia (What is dystonia?), muscle spasms, nervous system disorder, thinking abnormal. Haldol dosage: 2 Mg 1 A Day. Patient was hospitalized.

6745516-8 | Intentional Overdose, Self Injurious Behaviour
on May 23, 2010 Male patient from ITALY , 33 years of age, was treated with Haldol (View Usage). Patient had the following side effects: intentional overdose, self injurious behaviour. Haldol dosage: . During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

6743072-1 | Dysuria
Patient was taking Haldol (View Usage). After Haldol was administered, patient had the following side effects: dysuria on May 19, 2010 from AUSTRIA Additional patient health information: Male patient , 25 years of age, was diagnosed with schizophrenia and. Haldol dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ).

6733376-0 | Overdose, Self Injurious Behaviour
Adverse event was reported on May 12, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: UNITED STATES , 34 years of age, Patient experienced the following unwanted or unexpected effects: overdose, self injurious behaviour. During the same period patient was treated with LITHIUM (View Lithium Review and Lithium Label ), ARTANE (View Artane Review and Artane Label ), ELAVIL (View Elavil Review and Elavil Label ), INDERAL (View Inderal Review and Inderal Label ).

6730695-9 | Self Injurious Behaviour
on May 12, 2010 Male patient from ITALY , 37 years of age, was treated with Haldol (View Usage). Patient had the following side effects: self injurious behaviour. Haldol dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), AKINETON (View Akineton Review and Akineton Label ).

6725700-X | Blood Pressure Decreased, Pulmonary Embolism
on May 10, 2010 Male patient from AUSTRIA , 46 years of age, was diagnosed with delirium and was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: blood pressure decreased, pulmonary embolism (What is pulmonary embolism?). Haldol dosage: . During the same period patient was treated with NEUROTOP (View Neurotop Review and Neurotop Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6723609-9 | Dysuria
Patient was taking Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: dysuria on May 06, 2010 from AUSTRIA Additional patient health information: Male patient , child 10 years of age, was diagnosed with schizophrenia and. Haldol dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ).

6723167-9 | Pneumonia, Pulmonary Embolism
Adverse event was reported on May 10, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) . Location: AUSTRIA , 23 years of age, Patient had the following side effects: pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), SEROQUEL (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

6717024-1 | Dysphagia, Muscular Weakness, Parkinson's Disease, Quality Of Life Decreased
on May 06, 2010 Female patient from UNITED STATES , 53 years of age, weighting 195.0 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: dysphagia, muscular weakness, parkinson's disease (What is parkinson's disease?), quality of life decreased. Haldol dosage: Low Dose ? Monthly.

6716970-2 | Aggression, Haemorrhoids, Homicide, Impulse-control Disorder
on Apr 29, 2010 Male patient from NETHERLANDS , weighting 165.3 lb, was diagnosed with delusion, major depression, somnolence and was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, haemorrhoids, homicide, impulse-control disorder. Haldol dosage: . During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ).

6716969-6 | Suicide Attempt
Patient was taking Haldol (View Usage). Patient had the following side effects: suicide attempt on May 06, 2010 from BRAZIL Additional patient health information: Female patient , weighting 160.9 lb, was diagnosed with tobacco user and. Haldol dosage: . During the same period patient was treated with RIVOTRIL (View Rivotril Review and Rivotril Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), VARENICLINE (View Varenicline Review and Varenicline Label ). Patient was hospitalized.

6716968-4 | Cytolytic Hepatitis, Delirium, Eosinophilia, Pyrexia, Rhabdomyolysis
Adverse event was reported on Apr 30, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) was diagnosed with schizophrenia, delirium and. Location: FRANCE , 38 years of age, After Haldol was administered, patient had the following side effects: cytolytic hepatitis, delirium, eosinophilia, pyrexia, rhabdomyolysis. During the same period patient was treated with HALDOL DECANOAS (View Haldol Decanoas Review and Haldol Decanoas Label ), ABILIFY (View Abilify Review and Abilify Label ), THERALENE (View Theralene Review and Theralene Label ), CLOPIXOL (View Clopixol Review and Clopixol Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), TERCIAN (View Tercian Review and Tercian Label ), TERALITHE (View Teralithe Review and Teralithe Label ), NOZINAN (View Nozinan Review and Nozinan Label ). Patient was hospitalized.

6712751-4 | Pleurothotonus
on Apr 27, 2010 Male patient from SWITZERLAND , 66 years of age, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: pleurothotonus. Haldol dosage: .

6712750-2 | Eye Movement Disorder, Fall, Hallucination, Auditory, Headache
on Apr 27, 2010 Female patient from BRAZIL , 44 years of age, weighting 176.4 lb, was diagnosed with thyroid disorder, hallucination, sedation and was treated with Haldol (View Usage). Patient had the following side effects: eye movement disorder, fall (What is fall?), hallucination, auditory, headache (What is headache?). Haldol dosage: . During the same period patient was treated with PURAN T4 (View Puran T4 Review and Puran T4 Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AKINETON (View Akineton Review and Akineton Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ).

6708919-3 | Bronchopneumonia, Fall, Lethargy, Weight Decreased
Patient was taking Haldol (View Usage). After Haldol was administered, patient had the following side effects: bronchopneumonia, fall (What is fall?), lethargy, weight decreased on Apr 29, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 77 years of age, . Haldol dosage: . During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ).

6706734-8 | Coma, Intentional Overdose, Self Injurious Behaviour, Tachycardia, Vomiting
Adverse event was reported on Apr 28, 2010 by a Female patient taking Haldol (View Usage) (Dosage: ) was diagnosed with self injurious behaviour and. Location: ITALY , 30 years of age, Patient experienced the following unwanted or unexpected effects: coma, intentional overdose, self injurious behaviour, tachycardia, vomiting. During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6701519-0 | Conduction Disorder, Self Injurious Behaviour, Sluggishness, Sopor, Vomiting
on Apr 22, 2010 Female patient from ITALY , 32 years of age, was treated with Haldol (View Usage). Patient had the following side effects: conduction disorder, self injurious behaviour, sluggishness, sopor, vomiting. Haldol dosage: . During the same period patient was treated with SERENASE (View Serenase Review and Serenase Label ), ZELDOX (View Zeldox Review and Zeldox Label ).

6701518-9 | Agitation, Bradycardia, Coma, Mydriasis, Salivary Hypersecretion, Self Injurious Behaviour, Tremor
on Apr 22, 2010 Male patient from ITALY , 24 years of age, was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: agitation, bradycardia, coma, mydriasis, salivary hypersecretion, self injurious behaviour, tremor. Haldol dosage: . During the same period patient was treated with CARBOLITHIUM (View Carbolithium Review and Carbolithium Label ), AKINETON (View Akineton Review and Akineton Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), DEPAKENE (View Depakene Review and Depakene Label ), INSECTICIDES AND REPELLENTS (View Insecticides And Repellents Review and Insecticides And Repellents Label ).

6699731-2 | Cardiac Disorder, Fatigue, Palpitations, Sinus Tachycardia, Supraventricular Extrasystoles
Patient was taking Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac disorder, fatigue, palpitations, sinus tachycardia, supraventricular extrasystoles on Apr 20, 2010 from FRANCE Additional patient health information: Female patient , 41 years of age, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and. Haldol dosage: .

6696537-5 | Intentional Overdose, Self Injurious Behaviour, Sluggishness, Vomiting
Adverse event was reported on Apr 18, 2010 by a Female patient taking Haldol (View Usage) (Dosage: ) . Location: ITALY , 54 years of age, weighting 132.3 lb, Patient had the following side effects: intentional overdose, self injurious behaviour, sluggishness, vomiting. During the same period patient was treated with BENZODIAZEPINES NOS (View Benzodiazepines Nos Review and Benzodiazepines Nos Label ).

6696536-3 | Suicide Attempt
on Apr 16, 2010 Female patient from BRAZIL , weighting 160.9 lb, was diagnosed with tobacco user and was treated with Haldol (View Usage). After Haldol was administered, patient had the following side effects: suicide attempt. Haldol dosage: . During the same period patient was treated with RIVOTRIL (View Rivotril Review and Rivotril Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), VARENICLINE (View Varenicline Review and Varenicline Label ). Patient was hospitalized.

6696535-1 | Coma, Intentional Overdose, Self Injurious Behaviour, Tachycardia, Vomiting
on Apr 21, 2010 Female patient from ITALY , 30 years of age, was diagnosed with self injurious behaviour and was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: coma, intentional overdose, self injurious behaviour, tachycardia, vomiting. Haldol dosage: . During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6696534-X | Blood Pressure Decreased, Diabetes Mellitus, Hyperhidrosis, Increased Appetite, Restlessness, Tremor
Patient was taking Haldol (View Usage). Patient had the following side effects: blood pressure decreased, diabetes mellitus, hyperhidrosis, increased appetite, restlessness, tremor on Apr 15, 2010 from BRAZIL Additional patient health information: Male patient , 43 years of age, weighting 165.3 lb, was diagnosed with psychotic disorder (What is psychotic disorder?), schizophrenia and. Haldol dosage: . During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ).

6695383-6 | Akathisia, Gait Disturbance, Tachycardia
Adverse event was reported on Apr 23, 2010 by a Female patient taking Haldol (View Usage) (Dosage: 1 Mg Bid Po) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: UNITED STATES , 39 years of age, weighting 151.0 lb, After Haldol was administered, patient had the following side effects: akathisia, gait disturbance, tachycardia.

6691280-0 | Dyskinesia, Dystonia, Intentional Overdose, Self Injurious Behaviour
on Apr 14, 2010 Male patient from ITALY , 27 years of age, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, dystonia (What is dystonia?), intentional overdose, self injurious behaviour. Haldol dosage: .

6689764-4 | Neuroleptic Malignant Syndrome, Procalcitonin Increased
on Apr 12, 2010 Female patient from FRANCE , 84 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and was treated with Haldol (View Usage). Patient had the following side effects: neuroleptic malignant syndrome, procalcitonin increased. Haldol dosage: . Patient was hospitalized.

6687954-8 | Self Injurious Behaviour
Patient was taking Haldol (View Usage). After Haldol was administered, patient had the following side effects: self injurious behaviour on Apr 11, 2010 from ITALY Additional patient health information: Female patient , 35 years of age, weighting 172.0 lb, . Haldol dosage: 0.2% Batch Not Available. During the same period patient was treated with ANSIOLIN (0.5%) (View Ansiolin Review and Ansiolin Label ), DEPAKENE (View Depakene Review and Depakene Label ), SEROQUEL (View Seroquel Review and Seroquel Label ).

6687484-3 | Akathisia, Tardive Dyskinesia
Adverse event was reported on Apr 16, 2010 by a Male patient taking Haldol (View Usage) (Dosage: 75 Mg/every 2 We Every 2 Weeks) was diagnosed with schizophrenia and. Location: UNITED STATES , weighting 120.0 lb, Patient experienced the following unwanted or unexpected effects: akathisia, tardive dyskinesia.

6684270-5 | Self Injurious Behaviour
on Apr 08, 2010 Female patient from ITALY , 22 years of age, was treated with Haldol (View Usage). Patient had the following side effects: self injurious behaviour. Haldol dosage: . During the same period patient was treated with DEPAKIN (View Depakin Review and Depakin Label ).

6684035-4 |
on Apr 12, 2010 Male patient from BELGIUM , 26 years of age, was diagnosed with aggression, weight decreased and was treated with Haldol (View Usage). . Haldol dosage: . During the same period patient was treated with AMPHETAMINE SULFATE (View Amphetamine Sulfate Review and Amphetamine Sulfate Label ).

6680885-9 | Dysarthria, Overdose, Salivary Hypersecretion, Sluggishness
Patient was taking Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: dysarthria, overdose, salivary hypersecretion, sluggishness on Apr 07, 2010 from SWITZERLAND Additional patient health information: Female patient , 86 years of age, . Haldol dosage: . Patient was hospitalized.

6680884-7 | Dystonia, Hemiplegia
Adverse event was reported on Apr 07, 2010 by a Male patient taking Haldol (View Usage) (Dosage: ) . Location: FRANCE , 63 years of age, Patient had the following side effects: dystonia (What is dystonia?), hemiplegia.

6679354-1 |
on Apr 07, 2010 Male patient from BRAZIL , 33 years of age, was diagnosed with agitation and was treated with Haldol (View Usage). . Haldol dosage: . During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ), PIMOZIDE (View Pimozide Review and Pimozide Label ), FENERGAN (View Fenergan Review and Fenergan Label ).

6668543-8 | Self Injurious Behaviour, Sluggishness, Sopor
on Mar 27, 2010 Male patient from ITALY , 40 years of age, was treated with Haldol (View Usage). Patient experienced the following unwanted or unexpected effects: self injurious behaviour, sluggishness, sopor. Haldol dosage: . During the same period patient was treated with CIPRALEX (View Cipralex Review and Cipralex Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), VALIUM (View Valium Review and Valium Label ).

6657121-2 | Cardiogenic Shock, Fluid Overload, Left Ventricular Dysfunction, Respiratory Failure, Thrombocytopenia
Patient was taking Haldol (View Usage). Patient had the following side effects: cardiogenic shock, fluid overload, left ventricular dysfunction, respiratory failure, thrombocytopenia on Mar 19, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, weighting 202.8 lb, was diagnosed with acute coronary syndrome and. Haldol dosage: . During the same period patient was treated with NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NOREPINEPHRINE (View Norepinephrine Review and Norepinephrine Label ), REGULAR INSULIN (View Regular Insulin Review and Regular Insulin Label ), CHLORHEXIDINE GLUCONATE (View Chlorhexidine Gluconate Review and Chlorhexidine Gluconate Label ).